These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Oral tolerance in the control of experimental models of autoimmune disease. Staines NA; Harper N Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685 [TBL] [Abstract][Full Text] [Related]
27. [Regulatory T cells]. Marinić I; Gagro A; Rabatić S Acta Med Croatica; 2006 Dec; 60(5):447-56. PubMed ID: 17217101 [TBL] [Abstract][Full Text] [Related]
28. Definition of human autoimmunity--autoantibodies versus autoimmune disease. Lleo A; Invernizzi P; Gao B; Podda M; Gershwin ME Autoimmun Rev; 2010 Mar; 9(5):A259-66. PubMed ID: 19963079 [TBL] [Abstract][Full Text] [Related]
29. [Mucosal immunity and vaccine development]. Anjuère F; Czerkinsky C Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226 [TBL] [Abstract][Full Text] [Related]
30. Cell death recognition model for the immune system. Sun E Med Hypotheses; 2008; 70(3):585-96. PubMed ID: 17681705 [TBL] [Abstract][Full Text] [Related]
31. Natural versus adaptive regulatory T cells. Bluestone JA; Abbas AK Nat Rev Immunol; 2003 Mar; 3(3):253-7. PubMed ID: 12658273 [TBL] [Abstract][Full Text] [Related]
32. Natural regulatory T cells: mechanisms of suppression. Miyara M; Sakaguchi S Trends Mol Med; 2007 Mar; 13(3):108-16. PubMed ID: 17257897 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab. Majlessi L; Bordenave G Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234 [TBL] [Abstract][Full Text] [Related]